ESG Report 2021

B6 Product Responsibility General disclosure on: (a) the policies; and (b) compliance with relevant laws and regulations that have a significant impact on the issuer relating to health and safety, advertising, labeling and privacy matters relating to products and services provided and methods of redress. Quality Management Product Marketing and Promotion Customer Service Management Work and Information Security 44 48 49 54 B6.1 Customer Service Management Percentage of total products sold or shipped subject to recalls for safety and health reasons. 49 B6.2 Number of products and service-related complaints received and how they are dealt with. Customer Service Management 49 Protection of Intellectual Property B6.3 Description of practices relating to observing and protecting intellectual property rights. 22 B6.4 Description of quality assurance process and recall procedures. Quality Management 44 B6.5 Description of consumer data protection and privacy policies, how they are implemented and monitored. Work and Information Security 54 B7 Anti-corruption General disclosure on: (a) the policies; and (b) compliance with relevant laws and regulations that have a significant impact on the issuer relating to prevention of bribery, extortion, fraud and money laundering. Business Ethics 58 B7.1 Number of concluded legal cases regarding corrupt practices brought against the issuer or its employees during the reporting period and the outcomes of the cases. Business Ethics 58 B7.2 Description of preventive measures and whistle-blowing procedures, how they are implemented and monitored. Business Ethics 58 B7.3 Description of the anti-corruption training provided to the directors and employees. Business Ethics 58 B8 Community Investment General disclosure Policies on community engagement to understand the needs of the communities where the issuer operates and to ensure its activities take into consideration the communities' interests. Facilitating the Development of the Pharmaceutical Industry Active Support for Education Anti-epidemic and Disaster Relief Poverty Alleviation Elderly Care Animal Protection Care for the Community Cultivating a Healthy Lifestyle 20 84 85 85 86 86 87 88 Facilitating the Development of the Pharmaceutical Industry Active Support for Education Anti-epidemic and Disaster Relief Poverty Alleviation Elderly Care Animal Protection Care for the Community Cultivating a Healthy Lifestyle Focusing on contributing areas (e.g. education, environmental matters, labour needs, health, culture, sports). B8.1 20 84 85 85 86 86 87 88 Focus on contributing areas (e.g. education, environmental issues, labour needs, health, culture, sports). B8.2 Facilitating the Development of the Pharmaceutical Industry Active Support for Education Anti-epidemic and Disaster Relief Poverty Alleviation Elderly Care Animal Protection Care for the Community Cultivating a Healthy Lifestyle 20 84 85 85 86 86 87 88 ESG Indicators Overview Chapter Page 94 Environmental, Social and Governance Report 2021 The United Laboratories International Holdings Limited